Proteomics

Dataset Information

0

ARID1A-induced transcriptional reprogramming rewires signalling responses to drug treatment in melanoma


ABSTRACT: Proteomic study studying how ARID1A-mediated transcriptional rewiring drives resistance to MAPK inhibitors in melanoma by altering signalling pathways, immune interactions, and receptor dynamics, highlighting potential targets for combinatorial therapies.

INSTRUMENT(S): Orbitrap Exploris 480

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Melanocyte, Skin

DISEASE(S): Skin Melanoma

SUBMITTER: Evangelia Petsalaki  

LAB HEAD: Evangelia Petsalaki

PROVIDER: PXD058857 | Pride | 2025-01-14

REPOSITORIES: pride

Similar Datasets

2021-02-11 | PXD023471 | Pride
2022-04-04 | PXD031700 | Pride
2022-04-04 | PXD030288 | Pride
2017-08-23 | PXD000924 | Pride
2020-12-14 | PXD020254 | Pride
2021-03-16 | PXD020524 | Pride
2021-06-08 | PXD020788 | Pride
2017-10-18 | PXD003281 | Pride
2024-02-06 | PXD028127 | Pride
2017-06-01 | PXD003674 | Pride